Processing 00000000.tx.1: Estrogen and Alzheimers Disease: The Apolipoprotein Connection Neil J. 

Phrase: "Estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Alzheimers Disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "The Apolipoprotein Connection Neil J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0055966:Apolipoprotein J [Amino Acid, Peptide, or Protein,Immunologic Factor]
   902   C1413514:APOLIPOPROTEIN J [Gene or Genome]
   902   C2609437:Apolipoprotein J [Laboratory Procedure]
Processing 00000000.tx.2: MacLusky Center for Reproductive Sciences Columbia University Medical Center New York, New York 10032 Address all correspondence and requests for reprints to: Dr. 

Phrase: "MacLusky Center for Reproductive Sciences Columbia University Medical Center New York,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   775   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   756   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   756   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]

Phrase: "New York 10032"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0027976:New York [Geographic Area]
   827   C0205314:New [Temporal Concept]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "all correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "requests for reprints"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   756   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.3: Neil J. 

Phrase: "Neil J."
Processing 00000000.tx.4: MacLusky, Center for Reproductive Sciences, Columbia University Medical Center, 630 West 168th Street, New York, New York 10032. 

Phrase: "MacLusky,"

Phrase: "Center for Reproductive Sciences,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205099:Center [Spatial Concept]

Phrase: "Columbia University Medical Center,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   923   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   861   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   861   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   812   C0041740:University [Manufactured Object,Organization]
   812   C0205099:Center [Spatial Concept]
   812   C0205476:Medical [Functional Concept]
   812   C1551442:Columbia [Population Group]
   812   C3245499:Columbia [Health Care Related Organization]
   741 E C1551955:Columbian [Language]

Phrase: "630 West 168th Street,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0442658:Street [Manufactured Object]
   812   C1301826:Street [Finding]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "New York 10032."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0027976:New York [Geographic Area]
   827   C0205314:New [Temporal Concept]
Processing 00000000.tx.5: E-mail: nm274{at}columbia.edu . The contribution of estrogens to the prevention of neurodegenerative disorders has attracted considerable attention over the last few years as a result of conflicting data from clinical trials, some of which have shown protective effects of postmenopausal estrogen-based hormone replacement therapy (HRT), whereas others (including the recently concluded Womens Health Initiative trial) have revealed no significant benefit. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "nm274{at}columbia.edu ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "The contribution of estrogens"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880177:Contribution [Activity]

Phrase: "to the prevention"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0199176:Prevention [Therapeutic or Preventive Procedure]
  1000   C1706420:PREVENTION [Research Activity]
  1000   C2700409:prevention [Qualitative Concept]

Phrase: "of neurodegenerative disorders"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
  1000   C1522560:Neurodegenerative Disorders [Functional Concept]
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "has"

Phrase: "attracted"

Phrase: "considerable attention over the last few years"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0004268:Attention [Mental Process]

Phrase: "as a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of conflicting data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "from clinical trials,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0008976:Clinical Trials [Research Activity]
           Trial
  1000   C1096775:clinical trials [Intellectual Product]
   861   C0205210:Clinical [Qualitative Concept]

Phrase: "some of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205392:Some [Quantitative Concept]
   790   C3540770:Some [Intellectual Product]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "protective effects of postmenopausal estrogen-based hormone replacement therapy (HRT),"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   762   C0877035:Estrogen Effects [Finding]
   745   C1518681:Therapy Effect [Finding]
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "whereas"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the recently concluded Womens Health Initiative trial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0008976:Trial [Research Activity]

Phrase: ")"

Phrase: "have"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "no significant benefit."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0814225:Benefit [Quantitative Concept]
Processing 00000000.tx.6: Although the reason for these apparently discrepant results remains the subject of heated debate, a growing body of evidence suggests that individual women may exhibit variable neuroprotective responses to HRT, in part because of interactions with other known risk factors for neurodegenerative disease. 

Phrase: "Although"

Phrase: "the reason for these apparently discrepant results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392360:Reason [Idea or Concept]

Phrase: "remains"

Phrase: "the subject of heated debate,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0681850:Subject [Group]
   760   C1550501:{Subject} [Idea or Concept]
   760   C1706203:Subject [Idea or Concept]
   760   C2349001:Subject [Human]
   760   C2697811:Subject [Functional Concept]

Phrase: "a growing body of evidence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0242821:body [Human]
   760   C0460148:Body [Anatomical Structure]
   760   C1268086:Body [Anatomical Structure]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that individual women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043210:Women [Population Group]

Phrase: "may"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "variable neuroprotective responses to HRT,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0871261:responses [Organism Attribute]
   714 E C1704632:Response [Finding]
   714 E C1706817:Response [Intellectual Product]
   714 E C2911692:Response [Mental Process]

Phrase: "in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "because of interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "with other known risk factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0035648:risk factors [Quantitative Concept]
   901   C1553898:risk factors [Idea or Concept]
   827   C0035647:Risk [Qualitative Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "for neurodegenerative disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.7: One such risk factor, which modulates the effects of HRT on rates of cognitive decline in aging women, is the expression pattern of allelic variants of apolipoprotein E (apoE). 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "such risk factor,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035648:Risk factor [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "which"

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the effects of HRT"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C1518681:Therapy Effect [Finding]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0871208:Rate [Activity]
   966   C1521828:Rate [Quantitative Concept]

Phrase: "of cognitive decline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]

Phrase: "in aging women,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043210:Women [Population Group]

Phrase: "is"

Phrase: "the expression pattern of allelic variants of apolipoprotein E (apoE)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0449774:Pattern [Spatial Concept]
Processing 00000000.tx.8: The paper by Nathan et al. 

Phrase: "The paper by Nathan et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0030351:Paper [Manufactured Object]
   753   C1547566:Paper [Idea or Concept]
Processing 00000000.tx.9: (1) in this issue of Endocrinology indicates why this may be the case. 

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "in this issue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]

Phrase: "of Endocrinology"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   928 E C0694557:endocrinologic [Functional Concept]

Phrase: "indicates"

Phrase: "why"

Phrase: "this"

Phrase: "may"

Phrase: "be"

Phrase: "the case."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]
Processing 00000000.tx.10: Trophic effects of the natural ovarian estrogen, estradiol-17, on neurite growth in cultured mouse cerebral cortical neurons are reported to be critically dependent on apoE expression. 

Phrase: "Trophic effects of the natural ovarian estrogen,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0877035:Estrogen Effects [Finding]
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "estradiol-17,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "on neurite growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1753129:neurite growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "in cultured mouse cerebral cortical neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   873   C2333134:Cerebral cortical neuron [Cell]
   804   C0027882:Neurons [Cell]
   721 E C0521390:Neuronal [Immunologic Factor]

Phrase: "are"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "critically dependent on apoE expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]
Processing 00000000.tx.11: Moreover, responses to estradiol-17 are shown to be dependent on the type of apoE present: whereas estradiol-17 is neurotrophic in the presence of human apoE 2 or apoE 3, the apoE 4 variant, which has been associated with the progression of late onset Alzheimers disease, does not support this response. 

Phrase: "Moreover,"

Phrase: "responses to estradiol-17"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "dependent on the type of apoE present"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0851827:Dependent [Qualitative Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]

Phrase: ":"

Phrase: "whereas"

Phrase: "estradiol-17"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "is"

Phrase: "neurotrophic in the presence of human apoE 2"

Phrase: "or"

Phrase: "apoE 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0052199:Apolipoprotein E-3 [Amino Acid, Peptide, or Protein]
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the apoE 4 variant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205419:Variant [Qualitative Concept]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "which"

Phrase: "has"

Phrase: "been"

Phrase: "associated with the progression of late onset Alzheimers disease,"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   818   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   781   C0814122:late disease onset [Finding]
   764   C0002395:Alzheimers disease [Disease or Syndrome]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   762   C0242656:Disease Progression [Pathologic Function]
           progression
   762   C0243083:associated disease [Pathologic Function]
   762   C0277793:disease onset [Temporal Concept]
   762   C1947900:Disease progression NOS [Finding]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0205087:Late [Temporal Concept]
   742   C0332162:Onset [Qualitative Concept]
   742   C0449258:Progression [Functional Concept]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "this response."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]
Processing 00000000.tx.12: The concept that HRT might have beneficial effects on the aging brain evolved initially from studies in laboratory animals. 

Phrase: "The concept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178566:concept [Idea or Concept]

Phrase: "that HRT"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0282402:Hormone replacement therapy [Therapeutic or Preventive Procedure]
           hormone replacement
   913   C0279025:Hormone Therapy [Therapeutic or Preventive Procedure]
   901   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   827   C0019932:Hormone [Hormone]
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1363945:Therapy [Finding]
   827   C1555302:Replacement [Idea or Concept]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "might"

Phrase: "have"

Phrase: "beneficial effects on the aging brain"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "evolved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332253:evolved [Functional Concept]

Phrase: "initially from studies in laboratory animals."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0003064:Animals, Laboratory [Animal]
   783   C0681827:Laboratory studies [Laboratory Procedure]
   783   C0683949:animals studies [Animal]
   753   C0003062:Animals [Animal]
   753   C0022877:Laboratory [Manufactured Object,Organization]
   753   C0205265:Initially [Temporal Concept]
   753   C0947630:studies [Laboratory Procedure]
   753   C3244292:laboratory [Functional Concept]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]
Processing 00000000.tx.13: Almost 3 decades ago, estradiol-17 was shown to exert neurotrophic effects in tissue explants derived from the developing mouse hypothalamus and preoptic area (2). 

Phrase: "Almost 3 decades ago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C2981279:Decade [Quantitative Concept]

Phrase: "estradiol-17"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "neurotrophic effects in tissue explants"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "derived from the developing mouse hypothalamus"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1522183:Mouse Hypothalamus [Tissue]
   753   C0020663:Hypothalamus [Body Part, Organ, or Organ Component]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C1280712:Hypothalamus [Body Part, Organ, or Organ Component]
   753   C1441547:Derived [Qualitative Concept]
   753   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "preoptic area"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033063:Preoptic Area [Body Part, Organ, or Organ Component]
   861   C0017446:Area [Geographic Area]
   861   C0205146:Area [Spatial Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: Synaptogenic effects of estradiol-17 were later demonstrated to occur in the adult brain, including regions of the brain, such as the hippocampus, that are important for cognitive function (3, 4). 

Phrase: "Synaptogenic effects of estradiol-17"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "later"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur in the adult brain,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0001675:Adult [Age Group]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1706450:Adult [Human]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "regions of the brain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1273723:brain regions [Body Location or Region]
   737   C0017446:Region [Geographic Area]
   737   C0205147:Region [Spatial Concept]

Phrase: "such as the hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "that"

Phrase: "are"

Phrase: "important for cognitive function"

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.15: In various models of neuronal damage, natural and synthetic estrogens were reported to enhance cell survival (5), whereas estradiol-17 treatment was shown to enhance nonamyloidogenic processing of the Alzheimer amyloid precursor protein (6). 

Phrase: "In various models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]

Phrase: "of neuronal damage,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "natural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205296:Natural [Functional Concept]

Phrase: "and"

Phrase: "synthetic estrogens"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0014941:Estrogens, Synthetic [Organic Chemical,Pharmacologic Substance]
   861   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   827 E C2936882:Estrogen [Pharmacologic Substance]
   777 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "cell survival"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "estradiol-17 treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "nonamyloidogenic processing of the Alzheimer amyloid precursor protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0033666:protein processing [Molecular Function]
   744   C1709694:Processing [Activity]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.16: Estradiol-17 was also found to have positive effects on maintenance of the neurotransmitter systems that undergo degeneration in Alzheimers disease (7) and Parkinsons disease (8). 

Phrase: "Estradiol-17"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "was"

Phrase: "also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "positive effects on maintenance of the neurotransmitter systems"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "that"

Phrase: "undergo"

Phrase: "degeneration in Alzheimers disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011164:Degeneration [Pathologic Function]
   770   C1880269:Degeneration [Functional Concept]

Phrase: "(7"

Phrase: ")"

Phrase: "and"

Phrase: "Parkinsons disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   755   C1021144:Parkinsonia [Plant]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.17: Taken together, these observations provided strong mechanistic support for the concept that postmenopausal HRT might slow or prevent neurodegenerative processes. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "strong mechanistic support for the concept"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0183683:Support [Medical Device]
   753   C1521721:Support [Conceptual Entity]

Phrase: "that postmenopausal HRT"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0019930:Hormone Replacement Therapy, Post-Menopausal [Therapeutic or Preventive Procedure]
   923   C0282402:Hormone replacement therapy [Therapeutic or Preventive Procedure]
           hormone replacement
   875   C0279025:Hormone Therapy [Therapeutic or Preventive Procedure]
   861   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   812   C0035139:Replacement [Therapeutic or Preventive Procedure]
   812   C0039798:therapy [Functional Concept]
   812   C0087111:Therapy [Therapeutic or Preventive Procedure]
   812   C0559956:Replacement [Functional Concept]
   812   C1363945:Therapy [Finding]
   812   C1555302:Replacement [Idea or Concept]

Phrase: "might"

Phrase: "slow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439834:Slow [Qualitative Concept]

Phrase: "or"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "neurodegenerative processes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.18: Clinical trials have, in general, provided only mixed support for this hypothesis while simultaneously highlighting the potential health risks of long-term postmenopausal HRT use (1, 9, 10, 11). 

Phrase: "Clinical trials"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0008976:Clinical Trials [Research Activity]
           Trial
  1000   C1096775:clinical trials [Intellectual Product]
   861   C0205210:Clinical [Qualitative Concept]

Phrase: "have"

Phrase: ","

Phrase: "in general,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "only mixed support for this hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0183683:Support [Medical Device]
   753   C1521721:Support [Conceptual Entity]

Phrase: "while"

Phrase: "simultaneously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521115:simultaneously [Temporal Concept]

Phrase: "highlighting"

Phrase: "the potential health"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0018684:Health [Idea or Concept]
   761 E C0031206:healthiness [Finding]

Phrase: "risks of long-term postmenopausal HRT use"
Meta Candidates (Total=24; Excluded=0; Pruned=0; Remaining=24)
   818   C0019930:Hormone Replacement Therapy, Post-Menopausal [Therapeutic or Preventive Procedure]
   790   C0282402:Hormone replacement therapy [Therapeutic or Preventive Procedure]
           hormone replacement
   764   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   764   C0443252:Long-term [Temporal Concept]
   762   C0279025:Hormone Therapy [Therapeutic or Preventive Procedure]
   762   C1524063:Use of [Functional Concept]
   742   C0019932:Hormone [Hormone]
   742   C0035139:Replacement [Therapeutic or Preventive Procedure]
   742   C0035647:Risk [Qualitative Concept]
   742   C0039798:therapy [Functional Concept]
   742   C0042153:use [Functional Concept]
   742   C0087111:Therapy [Therapeutic or Preventive Procedure]
   742   C0205166:Long [Qualitative Concept]
   742   C0232970:postmenopausal [Temporal Concept]
   742   C0457083:Use [Functional Concept]
   742   C0559956:Replacement [Functional Concept]
   742   C1363945:Therapy [Finding]
   742   C1515273:Term [Temporal Concept]
   742   C1555302:Replacement [Idea or Concept]
   742   C1705313:Term [Idea or Concept]
   742   C1706317:Long [Qualitative Concept]
   742   C1947944:Use [Intellectual Product]
   742   C2826302:TERM [Intellectual Product]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "9,"

Phrase: "10,"

Phrase: "11"

Phrase: ")."
Processing 00000000.tx.19: Part of the problem appears to be that in human beings, unlike laboratory animals, effects of HRT may be confounded by a variety of other factors, which modulate or oppose the actions of the hormones. 

Phrase: "Part of the problem"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1292711:Part of [Spatial Concept]
   770   C0449719:Part [Spatial Concept]
   770   C1709471:Part [Quantitative Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "that in human beings,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0086418:Human [Human]

Phrase: "unlike laboratory animals,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003064:Animals, Laboratory [Animal]
   861   C0003062:Animals [Animal]
   861   C0022877:Laboratory [Manufactured Object,Organization]
   861   C3244292:laboratory [Functional Concept]

Phrase: "effects of HRT"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C1518681:Therapy Effect [Finding]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "confounded by a variety of other factors,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0960756:factor A [Organic Chemical]
   748   C1883525:Variety [Conceptual Entity]
   748   C2346866:Variety [Conceptual Entity]
   714   C1521761:Factor [Functional Concept]
   714   C2827422:Factor [Conceptual Entity]

Phrase: "which"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "or"

Phrase: "oppose"

Phrase: "the actions of the hormones."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441472:actions [Functional Concept]
   726 E C3266814:Action [Activity]
Processing 00000000.tx.20: One particularly important genetic factor appears to be the expression pattern of apoE. 

Phrase: "One particularly important genetic factor"
Meta Candidates (Total=17; Excluded=13; Pruned=0; Remaining=4)
   804   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   804   C0314603:Genetic [Functional Concept]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   748 E C0005615:Birth [Organism Function]
   748 E C0035150:Reproduction [Organism Function]
   748 E C0079946:origin [Classification]
   748 E C0439659:Origin [Temporal Concept]
   748 E C1550512:origin [Intellectual Product]
   748 E C1550722:birth [Idea or Concept]
   748 E C3245487:birth [Intellectual Product]
   721 E C0454729:Natal [Geographic Area]
   721 E C0559522:Genital [Body System]
   721 E C1546649:Genital [Intellectual Product]
   721 E C1550642:Genital [Body Substance]
   711 E C0205313:Original [Idea or Concept]
   711 E C2347409:Original [Occupational Activity]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the expression pattern of apoE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Pattern [Spatial Concept]
Processing 00000000.tx.21: Expression of different apoE alleles had previously been demonstrated to affect the risk of atherosclerosis (12) as well as the rate of progression of several human neurodegenerative diseases (13, 14), including Alzheimers dementia (15). 

Phrase: "Expression of different apoE alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "had"

Phrase: "previously"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the risk of atherosclerosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: "(12"

Phrase: ")"

Phrase: "as well as"

Phrase: "the rate of progression of several human neurodegenerative diseases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   745   C0026538:disease rate [Quantitative Concept]
   742   C0871208:Rate [Activity]
   742   C1521828:Rate [Quantitative Concept]

Phrase: "(13,"

Phrase: "14"

Phrase: ")"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Alzheimers dementia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0002395:alzheimers dementia [Disease or Syndrome]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.22: Intriguingly, patterns of apoE expression were also found to significantly influence responses to HRT (16). 

Phrase: "Intriguingly,"

Phrase: "patterns of apoE expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Patterns [Spatial Concept]

Phrase: "were"

Phrase: "also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "responses to HRT"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.23: The mechanism underlying this interaction remained uncertain. 

Phrase: "The mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "this interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "remained"

Phrase: "uncertain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0087130:Uncertain [Idea or Concept]
Processing 00000000.tx.24: One possibility was that it might reflect the known effects of apoE expression on atherosclerotic processes (12), with cerebral vascular compromise secondarily affecting the rate of cognitive decline (16). 

Phrase: "One possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "was"

Phrase: "that"

Phrase: "it"

Phrase: "might"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the known effects of apoE expression"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on atherosclerotic processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "with cerebral vascular compromise secondarily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2945640:compromise [Finding]

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the rate of cognitive decline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.25: An alternative hypothesis, however, was suggested by studies aimed at elucidating the effects of estradiol-17 on apoE expression in nerve cells. 

Phrase: "An alternative hypothesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1512571:Hypothesis [Idea or Concept]
   861   C1523987:Alternative [Conceptual Entity]

Phrase: "however,"

Phrase: "was"

Phrase: "suggested by studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0947630:studies [Laboratory Procedure]
   756 E C0557651:Study [Manufactured Object]
   756   C1705535:Suggest [Idea or Concept]
   756 E C2603343:Study [Research Activity]

Phrase: "aimed at elucidating"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C1947946:Aim [Idea or Concept]
   756   C2948600:Aim [Pharmacologic Substance]
   756   C3540471:AIM [Gene or Genome]
   756   C3540472:AIM [Functional Concept]

Phrase: "the effects of estradiol-17"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on apoE expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in nerve cells."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0027882:Nerve Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0027740:Nerve [Tissue]
   861   C0027757:NERVE [Tissue]
   861   C1280541:Nerve [Body Part, Organ, or Organ Component]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   805 E C0599851:Neural [Functional Concept]
   789 E C0027769:nervy [Sign or Symptom]
Processing 00000000.tx.26: Studies in mice demonstrated that expression of apoE in different brain regions varied with stage of the female reproductive cycle (17), consistent with the hypothesis that estradiol-17 might induce apoE expression in the brain, as had already been demonstrated for apoE in blood (18). 

Phrase: "Studies in mice"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0947630:studies [Laboratory Procedure]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "demonstrated"

Phrase: "that expression of apoE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in different brain regions"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C1273723:brain regions [Body Location or Region]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "varied with stage of the female reproductive cycle"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0015780:Female [Finding]
   744   C0035150:Reproductive [Organism Function]
   744   C0043210:female [Population Group]
   744   C0086287:female [Population Group]
   744   C0205390:Stage [Temporal Concept]
   744   C0748342:REPRODUCTIVE [Classification]
   744   C1300072:Stage [Clinical Attribute]
   744   C1306673:Stage [Qualitative Concept]
   744   C1511572:Cycle [Temporal Concept]
   744   C1705497:Female [Qualitative Concept]
   744   C1705498:Female [Qualitative Concept]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "consistent with the hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that estradiol-17"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "might"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoE expression in the brain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "as"

Phrase: "had"

Phrase: "already"

Phrase: "been"

Phrase: "demonstrated for apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.27: Addition of apoE 3 was found to produce effects like those of estradiol-17 on cultured neurons (19). 

Phrase: "Addition of apoE 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "effects like those of estradiol-17"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.28: Moreover, neuroprotective effects of estradiol-17 were abolished in transgenic mice homozygous for deletion of the apoE gene (20). 

Phrase: "Moreover,"

Phrase: "neuroprotective effects of estradiol-17"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0815279:Neuroprotective Effects [Functional Concept]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "abolished in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0025936:Mice, Transgenic [Mammal]
   770   C0003069:Transgenic [Animal]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]

Phrase: "homozygous for deletion of the apoE gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0019904:Homozygous [Organism Attribute]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.29: These observations raised the possibility that apoE might represent an integral component of the mechanisms mediating trophic responses of neurons to estrogen exposure. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "raised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442818:Raised [Quantitative Concept]

Phrase: "the possibility"

Phrase: "that apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an integral component of the mechanisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "trophic responses of neurons"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "to estrogen exposure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]
Processing 00000000.tx.30: The study by Nathan et al. 

Phrase: "The study by Nathan et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]
Processing 00000000.tx.31: (1) demonstrate that this is indeed the case. 

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "demonstrate"

Phrase: "that"

Phrase: "this"

Phrase: "is"

Phrase: "indeed"

Phrase: "the case."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]
Processing 00000000.tx.32: The growth-promoting effects of estradiol-17 not only depend on the expression of apoE, they are also highly dependent on the nature of the apoE subtype. 

Phrase: "The growth-promoting effects of estradiol-17"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0018270:'growth' NOS [Organism Function]
   748   C0033414:Promoting [Activity]
   748   C0220844:growth [Physiologic Function]
   748   C1280500:effects [Qualitative Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2911660:Growth [Activity]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "depend on the expression of apoE,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0725813:depend [Medical Device]

Phrase: "they"

Phrase: "are"

Phrase: "also highly dependent on the nature of the apoE subtype."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0851827:Dependent [Qualitative Concept]
   738   C1701901:Dependent [Qualitative Concept]
   738   C3244310:dependent [Functional Concept]
Processing 00000000.tx.33: In cultured cells from the adult mouse cerebral cortex, estradiol-17 increased both apoE levels and neurite outgrowth. 

Phrase: "In cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "from the adult mouse cerebral cortex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1522579:Mouse Cerebral Cortex [Tissue]
   861   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   812   C1176472:Cortex [Body Part, Organ, or Organ Component]
   812   C2700441:Cortex [Plant]

Phrase: "estradiol-17"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "both apoE levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "neurite outgrowth."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3158384:neurite outgrowth [Cell Function]
   861   C0085103:Neurite [Cell Component]
Processing 00000000.tx.34: The hormone had no effect on neurite outgrowth from mice lacking the apoE gene, or when only apoE 4 was exogenously supplied. 

Phrase: "The hormone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019932:Hormone [Hormone]
   928 E C0458083:Hormonal [Qualitative Concept]

Phrase: "had"

Phrase: "no effect on neurite outgrowth"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "from mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the apoE gene,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1412481:Apolipoprotein E gene [Gene or Genome]
   913   C1445865:Apolipoprotein gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "when"

Phrase: "only apoE 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   861   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "exogenously"

Phrase: "supplied."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1999230:Supplied [Activity]
   966 E C0243163:supply [Idea or Concept]
   966 E C0699914:supply [Quantitative Concept]
   966 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   966 E C1561604:supply [Functional Concept]
   966 E C1875802:SUPPLY [Medical Device]
Processing 00000000.tx.35: ApoE 2, an apoE variant that has been associated with reduced risk of Alzheimers disease and increased age of onset, increased neurite length more than apoE 3 in the presence of estradiol-17. 

Phrase: "ApoE 2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0052198:Apo E-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "an apoE variant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205419:Variant [Qualitative Concept]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "associated with reduced risk of Alzheimers disease"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0002395:Alzheimers disease [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C0243083:associated disease [Pathologic Function]
   774   C1281905:disease risk [Finding]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0035647:Risk [Qualitative Concept]
   748   C0392756:Reduced [Qualitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "increased age of onset,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   770   C0001779:Age [Organism Attribute]

Phrase: "increased neurite length more than apoE 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1444754:Length [Quantitative Concept]
   744   C1706316:LENGTH [Research Activity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of estradiol-17."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]
Processing 00000000.tx.36: Cultures from mice transgenic for human apoE 3 were capable of responding to estradiol-17, whereas those from mice expressing only apoE 4 were relatively insensitive. 

Phrase: "Cultures from mice"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0010453:Cultures [Idea or Concept]
   756 E C0220814:culture [Functional Concept]
   756 E C0430400:Culture [Laboratory Procedure]
   756 E C2242979:Culture [Laboratory Procedure]

Phrase: "transgenic for human apoE 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0003069:Transgenic [Animal]

Phrase: "were"

Phrase: "capable of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   761   C2698977:Capability [Qualitative Concept]

Phrase: "responding to estradiol-17,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   715 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   715 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "whereas"

Phrase: "those from mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "only apoE 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   861   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "relatively insensitive."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0237677:Insensitivity [Finding]
Processing 00000000.tx.37: Similarly, apoE 3 was accumulated in neurons to a greater extent than apoE 4 and was more effective in facilitating neuronal uptake of fatty acid. 

Phrase: "Similarly,"

Phrase: "apoE 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0052199:Apolipoprotein E-3 [Amino Acid, Peptide, or Protein]
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "accumulated in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0027882:Neurons [Cell]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "to a greater extent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1555603:Great extent [Qualitative Concept]
   861   C0439792:Extent [Spatial Concept]

Phrase: "than apoE 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "was"

Phrase: "more effective in facilitating neuronal uptake of fatty acid."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280519:effective [Qualitative Concept]
   742   C1704419:Effective [Qualitative Concept]
Processing 00000000.tx.38: These data are consistent with the hypothesis that apoE may play an integral role in supporting the neurotrophic effects of estradiol-17 and that patterns of apoE expression may have a profound impact on the sensitivity of the brain to estrogen action. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "consistent with the hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an integral role in supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "the neurotrophic effects of estradiol-17"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "that patterns of apoE expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Patterns [Spatial Concept]

Phrase: "may"

Phrase: "have"

Phrase: "a profound impact on the sensitivity of the brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1825598:IMPACT [Gene or Genome]

Phrase: "to estrogen action."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441472:Action [Functional Concept]
   861   C3266814:Action [Activity]
Processing 00000000.tx.39: These observations have important implications for future studies on the effects of HRT. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "have"

Phrase: "important implications for future studies"

Phrase: "on the effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "of HRT."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0282402:Hormone replacement therapy [Therapeutic or Preventive Procedure]
           hormone replacement
   913   C0279025:Hormone Therapy [Therapeutic or Preventive Procedure]
   901   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   827   C0019932:Hormone [Hormone]
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1363945:Therapy [Finding]
   827   C1555302:Replacement [Idea or Concept]
   755 E C0458083:Hormonal [Qualitative Concept]
Processing 00000000.tx.40: If expression of specific apoE alleles is required for estrogen to exert neurotrophic and neuroprotective effects, the pattern of apoE allele expression is likely to be important in determining the effectiveness of estrogen-based HRT. 

Phrase: "If"

Phrase: "expression of specific apoE alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "required for estrogen to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   770   C1514873:Required [Functional Concept]
   770   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "neurotrophic"

Phrase: "and"

Phrase: "neuroprotective effects,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0815279:Neuroprotective Effects [Functional Concept]
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "the pattern of apoE allele expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449774:Pattern [Spatial Concept]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "important in determining"

Phrase: "the effectiveness of estrogen-based HRT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1280519:Effectiveness [Qualitative Concept]
Processing 00000000.tx.41: Synergism between apoE subtype expression and the effects of HRT has already been demonstrated with respect to the progression of atherosclerosis in postmenopausal women, for which estrogen use appears to be particularly beneficial in patients with no apoE 4 allele (12). 

Phrase: "Synergism between apoE subtype expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0599739:synergism [Molecular Function]

Phrase: "and"

Phrase: "the effects of HRT"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C1518681:Therapy Effect [Finding]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "has"

Phrase: "already"

Phrase: "been"

Phrase: "demonstrated with respect to the progression of atherosclerosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004153:Atherosclerosis [Disease or Syndrome]
   744   C0242656:progression [Pathologic Function]
   744   C0449258:Progression [Functional Concept]
   744   C0679133:respect [Social Behavior]

Phrase: "in postmenopausal women,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0043210:Women [Population Group]
   861   C0232970:postmenopausal [Temporal Concept]

Phrase: "for which estrogen use"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0239301:ESTROGEN USE [Finding]
   861   C0042153:use [Functional Concept]
   861   C0457083:Use [Functional Concept]
   861   C1947944:Use [Intellectual Product]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "particularly beneficial in patients"

Phrase: "with no apoE 4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   812   C0002085:Allele [Gene or Genome]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.42: The same situation may well be true for effects on neurodegenerative processes. 

Phrase: "The same situation"

Phrase: "may"

Phrase: "well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "be"

Phrase: "true for effects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205238:True [Qualitative Concept]

Phrase: "on neurodegenerative processes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.43: Yaffe et al. 

Phrase: "Yaffe et al."
Processing 00000000.tx.44: (16) administered cognitive function tests over a number of years to women who were either taking estrogen-based HRT, had taken HRT at some time in the past, or who had never used HRT. 

Phrase: "(16"

Phrase: ")"

Phrase: "administered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521801:Administered [Functional Concept]
   966 E C1621583:Administer [Functional Concept]

Phrase: "cognitive function"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0392335:cognitive function [Mental Process]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1516691:Cognitive [Functional Concept]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "tests over a number of years"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0237753:*Number [Quantitative Concept]
   753   C0392366:Tests [Intellectual Product]
   753   C0439234:years [Temporal Concept]
   753   C0449788:Number [Quantitative Concept]
   719 E C0439508:/year [Temporal Concept]

Phrase: "to women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "who"

Phrase: "were"

Phrase: "either taking estrogen-based HRT,"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   868   C0014935:Estrogen Replacement Therapy [Therapeutic or Preventive Procedure]
           Estrogen Replacement
   863   C0474186:Estrogen hormone therapy [Therapeutic or Preventive Procedure]
   861   C0279494:estrogen therapy [Therapeutic or Preventive Procedure]
   845   C0086258:Estrogen Replacement [Therapeutic or Preventive Procedure]
   845   C0282402:Hormone replacement therapy [Therapeutic or Preventive Procedure]
           hormone replacement
   829   C0279025:Hormone Therapy [Therapeutic or Preventive Procedure]
   818   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   795   C0019932:Hormone [Hormone]
   795   C0035139:Replacement [Therapeutic or Preventive Procedure]
   795   C0039798:therapy [Functional Concept]
   795   C0087111:Therapy [Therapeutic or Preventive Procedure]
   795   C0559956:Replacement [Functional Concept]
   795   C1363945:Therapy [Finding]
   795   C1555302:Replacement [Idea or Concept]
   724 E C0458083:Hormonal [Qualitative Concept]

Phrase: "had"

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "HRT at some time"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0282402:Hormone replacement therapy [Therapeutic or Preventive Procedure]
           hormone replacement
   790   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   783   C0279025:Hormone Therapy [Therapeutic or Preventive Procedure]
   753   C0019932:Hormone [Hormone]
   753   C0035139:Replacement [Therapeutic or Preventive Procedure]
   753   C0039798:therapy [Functional Concept]
   753   C0087111:Therapy [Therapeutic or Preventive Procedure]
   753   C0559956:Replacement [Functional Concept]
   753   C1363945:Therapy [Finding]
   753   C1555302:Replacement [Idea or Concept]

Phrase: "in the past,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444637:Past [Temporal Concept]

Phrase: "or"

Phrase: "who"

Phrase: "had"

Phrase: "never used HRT."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   884   C0282402:Hormone replacement therapy [Therapeutic or Preventive Procedure]
           hormone replacement
   853   C0279025:Hormone Therapy [Therapeutic or Preventive Procedure]
   840   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   804   C0019932:Hormone [Hormone]
   804   C0035139:Replacement [Therapeutic or Preventive Procedure]
   804   C0039798:therapy [Functional Concept]
   804   C0087111:Therapy [Therapeutic or Preventive Procedure]
   804   C0559956:Replacement [Functional Concept]
   804   C1363945:Therapy [Finding]
   804   C1555302:Replacement [Idea or Concept]
   733 E C0458083:Hormonal [Qualitative Concept]
Processing 00000000.tx.45: In the women who did not express the apoE 4 variant, postmenopausal estrogen use reduced the risk of age-related cognitive impairment by almost 50%, compared with the women who never used estrogen. 

Phrase: "In the women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "who"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "express"

Phrase: "the apoE 4 variant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205419:Variant [Qualitative Concept]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "postmenopausal estrogen use"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0239301:ESTROGEN USE [Finding]
   827   C0042153:use [Functional Concept]
   827   C0457083:Use [Functional Concept]
   827   C1947944:Use [Intellectual Product]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the risk of age-related cognitive impairment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0035647:Risk [Qualitative Concept]

Phrase: "by almost 50%,"

Phrase: "compared with the women"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0043210:Women [Population Group]
   770   C1707455:Compared [Activity]

Phrase: "who never used estrogen."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.46: By contrast, apoE 4-positive women did not show a significant estrogen response (16). 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "apoE 4-positive women"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0043210:Women [Population Group]
   717   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a significant estrogen response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.47: These data are consistent with the hypothesis that analysis of apoE variant expression may be predictive of whether HRT is likely to have long-term beneficial cognitive effects. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "consistent with the hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that analysis of apoE variant expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "predictive of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0681890:predictive [Qualitative Concept]

Phrase: "whether"

Phrase: "HRT"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0282402:Hormone replacement therapy [Therapeutic or Preventive Procedure]
           hormone replacement
   913   C0279025:Hormone Therapy [Therapeutic or Preventive Procedure]
   901   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   827   C0019932:Hormone [Hormone]
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1363945:Therapy [Finding]
   827   C1555302:Replacement [Idea or Concept]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "have"

Phrase: "long-term beneficial cognitive effects."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   911   C0023983:Long-Term Effects [Phenomenon or Process]
   804   C1280500:effects [Qualitative Concept]
   771 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.48: Much remains to be done. 

Phrase: "Much"

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "done."
Processing 00000000.tx.49: One of the key questions that remains to be answered is the extent to which the data presented by Nathan et al. 

Phrase: "One of the key questions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "that"

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "answered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706817:Answer [Intellectual Product]

Phrase: "is"

Phrase: "the extent to which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "presented by Nathan et al."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0449450:Presented [Idea or Concept]
   726 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.50: (1) can be extrapolated to the normal brain. 

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "can"

Phrase: "be"

Phrase: "extrapolated to the normal brain."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.51: The work of Nathan et al. used cultures of dispersed neuronal and glial cells from the adult mouse cerebral cortex. 

Phrase: "The work of Nathan et al. used cultures of dispersed neuronal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0043227:Work [Occupational Activity]

Phrase: "and"

Phrase: "glial cells from the adult mouse cerebral cortex."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   776   C1524103:Mouse Glial Cell [Cell]
   770   C0027836:Glial Cells [Cell]
           Glial
   750   C1166657:cell cortex [Cell Component]
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.52: It will be important in future to determine whether the effects of estrogens on the aging brain involve comparable apoE-dependent mechanisms. 

Phrase: "It"

Phrase: "will"

Phrase: "be"

Phrase: "important in future to"

Phrase: "determine"

Phrase: "whether"

Phrase: "the effects of estrogens"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C0877035:effects estrogens [Finding]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on the aging brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "involve"

Phrase: "comparable apoE-dependent mechanisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0441712:Mechanisms [Functional Concept]
   771 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.53: Published evidence is consistent with the view that effects of estradiol-17 on the recovery of the mature brain from injury require apoE. 

Phrase: "Published evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "is"

Phrase: "consistent with the view"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that effects of estradiol-17"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on the recovery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237820:Recovery [Activity]
  1000   C1555688:recovery [Idea or Concept]
  1000   C2004454:Recovery [Organism Function]

Phrase: "of the mature brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "from injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3263722:Injury [Injury or Poisoning]
  1000   C3263723:Injury [Injury or Poisoning]

Phrase: "require"

Phrase: "apoE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.54: Thus, in mice, enhancement of synaptic sprouting by estradiol-17 in response to an entorhinal cortex lesions is dependent on apoE expression (21). 

Phrase: "Thus,"

Phrase: "in mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "enhancement of synaptic sprouting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   770   C2349975:Enhancement [Activity]

Phrase: "by estradiol-17"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to an entorhinal cortex lesions"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0175196:Entorhinal Cortex [Body Part, Organ, or Organ Component]
   901   C1289526:Entorhinal cortex [Body Part, Organ, or Organ Component]
   827   C0007776:Cortex [Body Part, Organ, or Organ Component]
   827   C0221198:lesions [Finding]
   827   C1176472:Cortex [Body Part, Organ, or Organ Component]
   827   C2700441:Cortex [Plant]
   793 E C1546698:Lesion [Intellectual Product]

Phrase: "is"

Phrase: "dependent on apoE expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.55: However, neuronal damage, perhaps including the cellular damage inevitably incurred during the preparation of primary cell cultures, may result in reexpression of estrogen receptor mechanisms that are normally expressed only in development (22). 

Phrase: "However,"

Phrase: "neuronal damage,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "perhaps"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the cellular damage inevitably"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0010957:Damage [Injury or Poisoning]
   827   C1883709:Damage [Functional Concept]

Phrase: "incurred during the preparation of primary cell cultures,"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   800   C1449562:Primary Cell Cultures [Laboratory Procedure]
   770   C0007585:Cell Cultures [Laboratory Procedure]
   767   C0920433:cell preparation [Laboratory Procedure]
   744   C0007634:Cell [Cell]
   744   C0010453:Cultures [Idea or Concept]
   744   C0205225:Primary [Qualitative Concept]
   744   C0439631:Primary [Therapeutic or Preventive Procedure]
   744   C0455052:Preparation [Health Care Activity]
   744   C1269647:Cell [Cell]
   744   C1521827:Preparation [Functional Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   711 E C0220814:culture [Functional Concept]
   711 E C0430400:Culture [Laboratory Procedure]
   711 E C2242979:Culture [Laboratory Procedure]

Phrase: "may"

Phrase: "result in reexpression of estrogen receptor mechanisms"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   778   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   748   C0441712:Mechanisms [Functional Concept]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]
   748   C2936882:Estrogen [Pharmacologic Substance]
   714 E C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "are"

Phrase: "normally"

Phrase: "expressed"

Phrase: "only in development"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0205171:Only [Quantitative Concept]
   790   C0243107:development [Physiologic Function]
   790   C0678723:Development [Organism Function]
   790   C1527148:Development [Functional Concept]
   790   C1720467:Only [Intellectual Product]
   718 E C0458003:Developmental [Qualitative Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.56: Hence, it remains to be established whether these findings can be extrapolated to the regulation of neuronal growth and survival in the uninjured brain. 

Phrase: "Hence,"

Phrase: "it"

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "whether"

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "can"

Phrase: "be"

Phrase: "extrapolated to the regulation of neuronal growth"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   804   C1160191:regulation of growth [Organism Function]
           growth regulation
   778   C0814002:Neuronal Growth [Cell Function,Organism Function]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C0521390:Neuronal [Immunologic Factor]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "survival in the uninjured brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]
Processing 00000000.tx.57: As postulated by Nathan et al. 

Phrase: "As"

Phrase: "postulated by Nathan et al."
Processing 00000000.tx.58: (1), in dementia or after trauma, degeneration and repair may be in dynamic balance, with cognitive decline occurring when degenerative processes predominate. 

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "in dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "or after trauma,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0043250:trauma [Injury or Poisoning]
   790   C0043251:Trauma [Injury or Poisoning]
   790   C1510467:trauma [Injury or Poisoning]
   790   C3263723:Trauma [Injury or Poisoning]

Phrase: "degeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011164:Degeneration [Pathologic Function]
  1000   C1880269:Degeneration [Functional Concept]

Phrase: "and"

Phrase: "repair"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043240:Repair, NOS [Organism Function]
  1000   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "be in dynamic balance,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0014653:Balance [Organism Function]
   770   C0205415:Balance [Functional Concept]
   770   C0560184:Balance [Finding]
   770   C0729333:Dynamic [Functional Concept]
   770   C2987476:Be [Conceptual Entity]

Phrase: "with cognitive decline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]

Phrase: "occurring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1709305:Occur [Activity]
   966   C2745955:OCCUR [Temporal Concept]

Phrase: "when"

Phrase: "degenerative processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "predominate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332251:Predominate [Qualitative Concept]
Processing 00000000.tx.59: However, significant trophic responses to estradiol-17 are also observed under conditions in which neurodegeneration is probably minimal (3, 4). 

Phrase: "However,"

Phrase: "significant trophic responses to estradiol-17"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "are"

Phrase: "also"

Phrase: "observed under conditions"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C1441672:Observed [Functional Concept]
   756   C0012634:condition [Disease or Syndrome]
   756   C0348080:Condition [Qualitative Concept]
   756   C1705253:Condition [Conceptual Entity]
   706 E C0009647:Conditioned [Mental Process]
   706 E C1701901:Conditional [Qualitative Concept]
   706 E C1963686:Conditional [Functional Concept]

Phrase: "in which neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "probably minimal"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0547040:Minimal [Qualitative Concept]
   861   C1524031:MINIMAL [Qualitative Concept]
   861   C2945599:Minimal [Qualitative Concept]
   789 E C1552614:minimum [Idea or Concept]
   789 E C2826545:MINIMUM [Quantitative Concept]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.60: These responses may contribute to the effects of estrogens on cognitive performance (23). 

Phrase: "These responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0871261:responses [Organism Attribute]
   966 E C1704632:Response [Finding]
   966 E C1706817:Response [Intellectual Product]
   966 E C2911692:Response [Mental Process]

Phrase: "may"

Phrase: "contribute to the effects of estrogens"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   783   C0877035:effects estrogens [Finding]
   753   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   753   C1280500:effects [Qualitative Concept]
   753   C1880177:Contribute [Activity]
   719 E C2348382:Effect [Qualitative Concept]
   719 E C2936882:Estrogen [Pharmacologic Substance]

Phrase: "on cognitive performance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597198:Performance [Individual Behavior]
   861   C1882330:Performance [Activity]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.61: It remains to be determined whether apoE is involved in the trophic actions of estradiol-17 under normal physiological, as opposed to pathological, conditions. 

Phrase: "It"

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined"

Phrase: "whether"

Phrase: "apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "involved in the trophic actions of estradiol-17"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   744   C0441472:actions [Functional Concept]
   744   C1314939:Involved [Functional Concept]
   711 E C3266814:Action [Activity]

Phrase: "under normal physiological,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205463:Physiological [Functional Concept]
   789 E C0031842:Physiology [Biomedical Occupation or Discipline]
   789 E C0031843:physiology [Physiologic Function]

Phrase: "as"

Phrase: "opposed to pathological, conditions."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0030664:Pathological [Biomedical Occupation or Discipline]
   770   C1521733:Pathological [Functional Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.62: A second question is how apoE is regulated by steroids other than estradiol-17. 

Phrase: "A second question"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522634:Question [Intellectual Product]

Phrase: "is"

Phrase: "how apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "regulated by steroids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0038317:Steroids [Steroid]
   790   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "other than estradiol-17."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]
Processing 00000000.tx.63: A wide range of estrogens and progestins have been used for HRT in postmenopausal women (10, 11). 

Phrase: "A wide range of estrogens"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1514721:Range [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]

Phrase: "and"

Phrase: "progestins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0033306:Progestins [Hormone,Pharmacologic Substance,Steroid]
   966 E C3536710:Progestin [Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "used for HRT"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   862   C0282402:Hormone replacement therapy [Therapeutic or Preventive Procedure]
           hormone replacement
   806   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   797   C0279025:Hormone Therapy [Therapeutic or Preventive Procedure]
   760   C0019932:Hormone [Hormone]
   760   C0035139:Replacement [Therapeutic or Preventive Procedure]
   760   C0039798:therapy [Functional Concept]
   760   C0087111:Therapy [Therapeutic or Preventive Procedure]
   760   C0559956:Replacement [Functional Concept]
   760   C1273517:used [Finding]
   760   C1363945:Therapy [Finding]
   760   C1555302:Replacement [Idea or Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "in postmenopausal women"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0043210:Women [Population Group]
   861   C0232970:postmenopausal [Temporal Concept]

Phrase: "(10,"

Phrase: "11"

Phrase: ")."
Processing 00000000.tx.64: It remains to be determined how these different steroids affect apoE expression. 

Phrase: "It"

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined"

Phrase: "how"

Phrase: "these different steroids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038317:Steroids [Steroid]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "apoE expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.65: The question of the specificity of the apoE response is critical because of the possibility that some combinations of hormonal agents could abrogate the beneficial effects of natural estrogens. 

Phrase: "The question of the specificity of the apoE response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1522634:Question [Intellectual Product]

Phrase: "is"

Phrase: "critical because of the possibility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511545:Critical [Qualitative Concept]

Phrase: "that"

Phrase: "some combinations of hormonal agents"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   764   C1879672:Agent Combination [Therapeutic or Preventive Procedure]
   760   C0453882:Combinations [Manufactured Object]
   726 E C0205195:Combination [Qualitative Concept]
   726 E C1947911:Combination [Physical Object]

Phrase: "could"

Phrase: "abrogate"

Phrase: "the beneficial effects of natural estrogens."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0877035:effects estrogens [Finding]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.66: For example, Nilsen and Brinton (24) have reported that whereas progesterone and 19-norprogesterone both potentiate the neuroprotective effects of estradiol-17, the opposite effect is observed with medroxyprogesterone acetate, the synthetic progestin used in the Womens Health Initiative trial. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "Nilsen"

Phrase: "and"

Phrase: "Brinton"

Phrase: "(24"

Phrase: ")"

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "whereas"

Phrase: "progesterone"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
  1000   C2757070:Progesterone [Pharmacologic Substance]
   944 E C0010094:Corpus luteum hormone [Hormone]
   944 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "19-norprogesterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045076:19-norprogesterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "both"

Phrase: "potentiate"

Phrase: "the neuroprotective effects of estradiol-17,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0815279:Neuroprotective Effects [Functional Concept]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "the opposite effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "observed with medroxyprogesterone acetate,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0065864:medroxyprogesterone acetate [Hormone,Pharmacologic Substance,Steroid]
   777 E C0699700:Depo-Provera [Pharmacologic Substance,Steroid]
   777 E C0699702:Provera [Pharmacologic Substance,Steroid]
   770   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   770   C0025147:Medroxyprogesterone [Hormone,Pharmacologic Substance,Steroid]
   770   C1441672:Observed [Functional Concept]

Phrase: "the synthetic progestin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033306:Progestin [Hormone,Pharmacologic Substance,Steroid]
   861   C3536710:Progestin [Pharmacologic Substance]

Phrase: "used in the Womens Health Initiative trial."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   778   C0080339:Womens Health [Biomedical Occupation or Discipline]
   748   C0008976:Trial [Research Activity]
   748   C0018684:Health [Idea or Concept]
   748   C0424093:Initiative [Mental Process]
   748   C1273517:used [Finding]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.67: Whether or not apoE expression is affected by other steroids is also important because of the fact that estradiol-17 is not the only hormonal steroid with neuroprotective and neurotrophic properties. 

Phrase: "Whether"

Phrase: "or"

Phrase: "not apoE expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "affected by other steroids"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0038317:Steroids [Steroid]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   737 E C0001721:Affect [Mental Process]

Phrase: "is"

Phrase: "also important because of the fact"

Phrase: "that estradiol-17"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the only hormonal steroid with neuroprotective"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0038317:Steroid [Steroid]

Phrase: "and"

Phrase: "neurotrophic properties."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]
Processing 00000000.tx.68: Recent work suggests that androgens may confer protection against neurodegenerative processes. 

Phrase: "Recent work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that androgens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0002844:Androgens [Hormone,Pharmacologic Substance]
   966 E C3536949:Androgen [Pharmacologic Substance]

Phrase: "may"

Phrase: "confer"

Phrase: "protection against neurodegenerative processes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1545588:Protection [Finding]
Processing 00000000.tx.69: Men with higher free testosterone levels appear to have a lower risk of developing Alzheimers disease (25), whereas reduced levels of the principal adrenal androgen, dehydroepiandrosterone, have been reported in Alzheimers disease patients (26). 

Phrase: "Men with higher free testosterone levels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0025266:Men [Population Group]
   719 E C0024554:MAN [Finding]
   719 E C0086418:Man [Human]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "a lower risk of developing Alzheimers disease"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   774   C1281905:disease risk [Finding]
   762   C3272281:Low Risk [Finding]
   762   C3538919:Low Risk [Quantitative Concept]
   748   C0035647:Risk [Qualitative Concept]
   748   C0441994:Lower [Spatial Concept]
   748   C1548802:Lower [Body Location or Region]
   748   C2003888:Lower [Activity]
   714 E C0205251:low [Qualitative Concept]
   714 E C1299352:Low [Qualitative Concept]
   714 E C1550472:low [Idea or Concept]

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "reduced levels of the principal adrenal androgen,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0919646:Androgen level [Laboratory Procedure]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "dehydroepiandrosterone,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0011185:dehydroepiandrosterone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0373598:Dehydroisoandrosterone [Laboratory Procedure]

Phrase: "have"

Phrase: "been"

Phrase: "reported in Alzheimers disease patients"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   806   C0002395:Alzheimers disease [Disease or Syndrome]
   781   C0747307:patients report [Intellectual Product]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.70: In laboratory studies, androgens and progestins have been reported to elicit neurotrophic and neuroprotective effects under a variety of experimental conditions (24, 27, 28). 

Phrase: "In laboratory studies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0681827:Laboratory studies [Laboratory Procedure]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "androgens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0002844:Androgens [Hormone,Pharmacologic Substance]
   966 E C3536949:Androgen [Pharmacologic Substance]

Phrase: "and"

Phrase: "progestins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0033306:Progestins [Hormone,Pharmacologic Substance,Steroid]
   966 E C3536710:Progestin [Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "neurotrophic"

Phrase: "and"

Phrase: "neuroprotective effects under a variety of experimental conditions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0815279:Neuroprotective Effects [Functional Concept]
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "(24,"

Phrase: "27,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.71: Although in some cases these effects may involve either interactions with estrogen or intermediate estrogen biosynthesis, in others they clearly do not (27). 

Phrase: "Although in some cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "these effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "involve"

Phrase: "either interactions with estrogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704675:Interaction [Functional Concept]

Phrase: "or"

Phrase: "intermediate estrogen biosynthesis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1157310:estrogen biosynthesis [Molecular Function]
   827   C0005572:biosynthesis [Functional Concept]
   827   C0220781:Biosynthesis [Biologic Function]

Phrase: "in others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "they clearly"

Phrase: "do"

Phrase: "not (27"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: ")."
Processing 00000000.tx.72: An intriguing hypothesis for future study is that apoE expression may represent a common link in steroid-activated neurotrophic responses. 

Phrase: "An intriguing hypothesis for future study"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "that apoE expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a common link in steroid-activated neurotrophic responses."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1517892:Link [Intellectual Product]
   744   C1704666:Link [Intellectual Product]
Processing 00000000.tx.73: If so, effects of androgens, like those of estrogens, may be influenced by apoE genotype. 

Phrase: "If"

Phrase: "so,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "effects of androgens,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   841   C3179300:Androgen Effects [Physiologic Function]
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "like those"

Phrase: "of estrogens,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   966 E C2936882:Estrogen [Pharmacologic Substance]
   916 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "influenced by apoE genotype."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.74: Interestingly, this possibility has already been raised by preliminary clinical studies, which demonstrated interactions between testosterone and apoE 4 expression in men with Alzheimers disease, as well as an association between apoE 4 and circulating testosterone levels in men without the disease (29). 

Phrase: "Interestingly,"

Phrase: "this possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "has"

Phrase: "already"

Phrase: "been"

Phrase: "raised by preliminary clinical studies,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0008972:Clinical Studies [Research Activity]
   760   C0205210:Clinical [Qualitative Concept]
   760   C0439611:Preliminary [Temporal Concept]
   760   C0442818:Raised [Quantitative Concept]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "which"

Phrase: "demonstrated"

Phrase: "interactions between testosterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "apoE 4 expression in men"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "with Alzheimers disease,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "as well as"

Phrase: "an association between apoE 4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "circulating testosterone levels in men"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   773   C0428412:testosterone level [Laboratory or Test Result]
   773   C0523912:Testosterone level [Laboratory Procedure]
   760   C0039601:Testosterone [Hormone,Pharmacologic Substance,Steroid]
   760   C0175630:Circulating [Functional Concept]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
   704 E C0113075:Depo-testosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "without the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.75: These observations raise the possibility that the relationship between apoE expression and gonadal steroids may be multifactorial, with the apoE 4 allele directly affecting the risk of neurodegenerative disease via effects on neuronal growth and survival, as well as indirectly via reductions in testicular androgen secretion. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "raise"

Phrase: "the possibility"

Phrase: "that"

Phrase: "the relationship between apoE expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439849:Relationship [Qualitative Concept]
   753   C1705630:Relationship [Idea or Concept]
   753   C1706279:Relationship [Idea or Concept]
   753   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "gonadal steroids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036884:gonadal steroids [Hormone,Pharmacologic Substance]
   861   C0038317:Steroids [Steroid]

Phrase: "may"

Phrase: "be"

Phrase: "multifactorial,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1837655:Multifactorial [Finding]

Phrase: "with the apoE 4 allele directly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   937   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   804   C0002085:Allele [Gene or Genome]
   717   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the risk of neurodegenerative disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "via effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "on neuronal growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0814002:Neuronal Growth [Cell Function,Organism Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "survival,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "as well as"

Phrase: "indirectly via reductions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0301630:reductions [Natural Phenomenon or Process]
   790   C0441610:reductions [Therapeutic or Preventive Procedure]
   756 E C0392756:Reduction [Qualitative Concept]

Phrase: "in testicular androgen secretion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C3271399:androgen secretion [Organ or Tissue Function]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
Processing 00000000.tx.76: Perhaps the most intriguing aspect of the observations of Nathan et al. 

Phrase: "Perhaps"

Phrase: "the most intriguing aspect of the observations of Nathan et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1547011:Aspect [Quantitative Concept]
   738   C1879746:Aspect [Qualitative Concept]
Processing 00000000.tx.77: (1), however, is the potential for development of novel strategies for replacement therapy designed to directly target the regulation of neural apoE expression. 

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "however,"

Phrase: "is"

Phrase: "the potential for development of novel strategies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3245505:Potential [Qualitative Concept]

Phrase: "for replacement therapy"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   861   C0035139:Replacement [Therapeutic or Preventive Procedure]
   861   C0039798:therapy [Functional Concept]
   861   C0087111:Therapy [Therapeutic or Preventive Procedure]
   861   C0559956:Replacement [Functional Concept]
   861   C1363945:Therapy [Finding]
   861   C1555302:Replacement [Idea or Concept]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883351:To [Qualitative Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "the regulation of neural apoE expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0598959:neural regulation [Organ or Tissue Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.78: The adverse effects of conventional HRT are primarily associated with responses that do not involve the brain, including alterations in coagulation factors, enhancing the risk of stroke, as well as trophic effects on the reproductive organs, resulting in increased risks for breast and endometrial cancer (10, 11). 

Phrase: "The adverse effects of conventional HRT"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   776   C0879626:therapy adverse effect [Pathologic Function]
           Adverse effects
   770   C0001688:adverse effects [Functional Concept]
   750   C1518681:Therapy Effect [Finding]
   744   C1280500:effects [Qualitative Concept]
   737 E C0559546:Adverse Effect [Finding]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "primarily"

Phrase: "associated with responses"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0871261:responses [Organism Attribute]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1704632:Response [Finding]
   756 E C1706221:Associate [Professional or Occupational Group]
   756 E C1706817:Response [Intellectual Product]
   756 E C2911692:Response [Mental Process]

Phrase: "that"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involve"

Phrase: "the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "alterations in coagulation factors,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   848   C1371466:Coagulation Factor Alteration [Cell Function]
   848   C3537077:Coagulation Factor Alteration [Cell Function]
   737   C1515926:Alteration [Idea or Concept]

Phrase: "enhancing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2349975:Enhance [Activity]

Phrase: "the risk of stroke,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1277291:Stroke risk [Intellectual Product]
   770   C0035647:Risk [Qualitative Concept]

Phrase: "as well as"

Phrase: "trophic effects on the reproductive organs,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "resulting in increased risks"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0332294:Resulting in [Functional Concept]
   770   C0035647:Risks [Qualitative Concept]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C0678226:resulting [Functional Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "for breast"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0006141:Breast [Body Part, Organ, or Organ Component]
  1000   C1268990:Breast [Body Part, Organ, or Organ Component]
   944 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   944 E C1521735:Pectoral [Qualitative Concept]
   916 E C0817096:Chest [Body Location or Region]
   916 E C1527391:Chest [Body Location or Region]

Phrase: "and"

Phrase: "endometrial cancer"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0007103:Endometrial Cancer [Neoplastic Process]
  1000   C0476089:Endometrial Cancer [Neoplastic Process]
  1000   C1883486:Endometrial Cancer [Neoplastic Process]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0227843:Endometrial [Spatial Concept]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]
   789 E C0014180:Endometria [Body Part, Organ, or Organ Component]
   789 E C1269566:Endometrium [Body Part, Organ, or Organ Component]

Phrase: "(10,"

Phrase: "11"

Phrase: ")."
Processing 00000000.tx.79: If regulation of apoE expression is indeed a critical component of the mechanisms mediating neuroprotective responses to estradiol-17, direct targeting of apoE regulation in the brain might mimic the beneficial central effects of this hormone without the adverse risks associated with conventional HRT. 

Phrase: "If"

Phrase: "regulation of apoE expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "is"

Phrase: "indeed"

Phrase: "a critical component of the mechanisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "neuroprotective responses to estradiol-17,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "direct targeting of apoE regulation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   773   C1550500:direct target [Idea or Concept]
   753   C1521840:Targeting [Functional Concept]
   719 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "might"

Phrase: "mimic"

Phrase: "the beneficial central effects of this hormone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "without the adverse risks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035647:Risks [Qualitative Concept]

Phrase: "associated with conventional HRT."
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   833   C0282402:Hormone replacement therapy [Therapeutic or Preventive Procedure]
           hormone replacement
   790   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   783   C0279025:Hormone Therapy [Therapeutic or Preventive Procedure]
   783   C2945704:Conventional Therapy [Therapeutic or Preventive Procedure]
   753   C0019932:Hormone [Hormone]
   753   C0035139:Replacement [Therapeutic or Preventive Procedure]
   753   C0039798:therapy [Functional Concept]
   753   C0087111:Therapy [Therapeutic or Preventive Procedure]
   753   C0439858:Conventional [Qualitative Concept]
   753   C0559956:Replacement [Functional Concept]
   753   C1363945:Therapy [Finding]
   753   C1555302:Replacement [Idea or Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.80: Such an approach seems at least potentially feasible, because the receptor systems mediating the effects of estrogens on central apoE synthesis may well be different from those found in nonneural estrogen target organs. 

Phrase: "Such"

Phrase: "an approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "seems at least potentially feasible,"

Phrase: "because"

Phrase: "the receptor systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "the effects of estrogens"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C0877035:effects estrogens [Finding]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on central apoE synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0220781:synthesis [Biologic Function]
   812   C1883254:Synthesis [Activity]

Phrase: "may"

Phrase: "well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "be"

Phrase: "different from those"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1705242:Different [Qualitative Concept]
   718 E C1705241:*Difference [Quantitative Concept]

Phrase: "found in nonneural estrogen target organs."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   753   C0150312:Found [Quantitative Concept]
   753   C0178784:organs [Body Part, Organ, or Organ Component]
   753   C1521840:Target [Functional Concept]
   753   C2936882:Estrogen [Pharmacologic Substance]
   753   C2986546:TARGET [Diagnostic Procedure]
   719 E C0243095:Find [Finding]
Processing 00000000.tx.81: Thus, estradiol-17, an estrogen with weak systemic hormonal activity, is fully capable of inducing apoE synthesis and release in mouse cerebral cortex and cultured glial cells (30, 31). 

Phrase: "Thus,"

Phrase: "estradiol-17,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "an estrogen with weak systemic hormonal activity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   748   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "is"

Phrase: "fully capable of inducing apoE synthesis"

Phrase: "and"

Phrase: "release in mouse cerebral cortex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "cultured glial cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   913   C0007600:cultured cells [Cell]
   913   C0007635:Cultured Cells [Cell]
   913   C3282338:Cells, Cultured [Cell]
   901   C0027836:Glial Cells [Cell]
           Glial
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C1087003:Glia [Plant]

Phrase: "(30,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.82: As a better understanding of the molecular mechanisms underlying the effects of estrogen on apoE expression evolves, it may be possible to identify agents that will selectively up-regulate apoE expression in the brain with no significant adverse effects on tissues elsewhere in the body.  

Phrase: "As a better understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0162340:Understanding [Mental Process]

Phrase: "of the molecular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "the effects of estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C0877035:Estrogen Effects [Finding]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on apoE expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "evolves"

Phrase: ","

Phrase: "it"

Phrase: "may"

Phrase: "be"

Phrase: "possible to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "identify"

Phrase: "agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0450442:Agent [Chemical Viewed Functionally]
   966   C1254351:Agent [Pharmacologic Substance]
   966   C1521826:Agent [Intellectual Product]

Phrase: "that"

Phrase: "will"

Phrase: "selectively"

Phrase: "up-regulate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547043:Up [Spatial Concept]
   861   C1282911:Up [Spatial Concept]

Phrase: "apoE expression in the brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "with no significant adverse effects"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0001688:adverse effects [Functional Concept]
   901   C0879626:Adverse effects [Pathologic Function]
   867 E C0559546:Adverse Effect [Finding]
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "on tissues elsewhere"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "in the body."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242821:body [Human]
  1000   C0460148:Body [Anatomical Structure]
  1000   C1268086:Body [Anatomical Structure]
   916 E C1995017:Bodies [Cell Component]
Processing 00000000.tx.83: Footnotes  Abbreviations: apoE, Apolipoprotein E; 

Phrase: "Footnotes  Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0000723:Abbreviations [Intellectual Product]

Phrase: ":"

Phrase: "apoE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.84: HRT, hormone replacement therapy. 

Phrase: "HRT,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0282402:Hormone replacement therapy [Therapeutic or Preventive Procedure]
           hormone replacement
   913   C0279025:Hormone Therapy [Therapeutic or Preventive Procedure]
   901   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   827   C0019932:Hormone [Hormone]
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1363945:Therapy [Finding]
   827   C1555302:Replacement [Idea or Concept]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "hormone replacement therapy."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0282402:Hormone replacement therapy [Therapeutic or Preventive Procedure]
           hormone replacement
   913   C0279025:Hormone Therapy [Therapeutic or Preventive Procedure]
   901   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   827   C0019932:Hormone [Hormone]
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1363945:Therapy [Finding]
   827   C1555302:Replacement [Idea or Concept]
   755 E C0458083:Hormonal [Qualitative Concept]
Processing 00000000.tx.85: Received April 2, 2004. 

Phrase: "Received April 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "2004."
Processing 00000000.tx.86: Accepted for publication April 7, 2004.  

Phrase: "Accepted for publication April 7,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1272684:Accepted [Qualitative Concept]
   760   C1548435:Accepted [Idea or Concept]
   760   C1704324:Publication [Intellectual Product]
   726 E C1548601:Accept [Idea or Concept]

Phrase: "2004."
Processing 00000000.tx.87: References Top References  Nathan BP, Barsukova AG, Shen F, McAsey M, Struble RG 2004 Estrogen facilitates neurite extension via apolipoprotein E in cultured adult mouse cortical neurons. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Nathan BP,"

Phrase: "Barsukova AG,"

Phrase: "Shen F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "McAsey M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Struble RG 2004 Estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "facilitates"

Phrase: "neurite extension via apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0231448:Extension [Functional Concept]
   760   C1880641:Extension [Conceptual Entity]

Phrase: "in cultured adult mouse cortical neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0027882:Neurons [Cell]
   721 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.88: Endocrinology 145:30653073[Abstract/Free FullText] Toran-Allerand CD 1976 Sex steroids and the development of the newborn mouse hypothalamus and preoptic area in vitro: Implication for sexual differentiation. 

Phrase: "Endocrinology 145"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "30653073"

Phrase: "[Abstract/Free FullText"

Phrase: "] Toran-Allerand CD 1976 Sex steroids"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0009253:Sex [Organism Function]
   799   C0036864:Sex [Behavior]
   799   C0038317:Steroids [Steroid]
   799   C0079399:sex [Organism Attribute]
   799   C1314687:Sex [Finding]
   799   C1522384:sex [Organism Attribute]

Phrase: "and"

Phrase: "the development of the newborn mouse hypothalamus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1818423:hypothalamus development [Organ or Tissue Function]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "preoptic area"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033063:Preoptic Area [Body Part, Organ, or Organ Component]
   861   C0017446:Area [Geographic Area]
   861   C0205146:Area [Spatial Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: ":"

Phrase: "Implication for sexual differentiation."
Processing 00000000.tx.89: Brain Res 189:413427[CrossRef] Woolley CS, McEwen BS 1992 Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. 

Phrase: "Brain Res 189"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "413427"

Phrase: "[CrossRef"

Phrase: "] Woolley CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "McEwen BS 1992 Estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   756 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   756 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "fluctuation in hippocampal synapse density"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0231239:Fluctuation [Sign or Symptom]
   760   C0231241:Fluctuation [Temporal Concept]
   760   C2827773:Fluctuation% [Qualitative Concept]

Phrase: "during the estrous cycle"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0025329:estrous cycle [Organism Function]
  1000   C0950151:Estrous Cycle [Organism Function]
   861   C0014948:estrous [Organism Function]
   861   C1511572:Cycle [Temporal Concept]

Phrase: "in the adult rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
Processing 00000000.tx.90: J Neurosci 12:25492554[Abstract] Hao J, Janssen WG, Tang Y, Roberts JA, McKay H, Lasley B, Allen PB, Greengard P, Rapp PR, Kordower JH, Hof PR, Morrison JH 2003 Estrogen increases the number of spinophilin-immunoreactive spines in the hippocampus of young and aged female rhesus monkeys. 

Phrase: "J Neurosci 12"

Phrase: ":"

Phrase: "25492554"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hao J,"

Phrase: "Janssen WG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043092:WG [Disease or Syndrome]

Phrase: "Tang Y,"

Phrase: "Roberts JA,"

Phrase: "McKay H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Lasley B,"

Phrase: "Allen PB,"

Phrase: "Greengard P,"

Phrase: "Rapp PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: "Kordower JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Hof PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: "Morrison JH 2003 Estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the number of spinophilin-immunoreactive spines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "in the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "of young"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "and"

Phrase: "aged female rhesus monkeys."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024400:rhesus monkeys [Mammal]
           Rhesus
   812   C0026447:Monkeys [Mammal]
Processing 00000000.tx.91: J Comp Neurol 465:540550[CrossRef][Medline] Green PS, Simpkins JW 2000 Neuroprotective effects of estrogens: potential mechanisms of action. 

Phrase: "J Comp Neurol 465"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0056167:COMP [Therapeutic or Preventive Procedure]
   812   C1456376:COMP [Gene or Genome]

Phrase: ":"

Phrase: "540550"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Green PS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "Simpkins JW 2000 Neuroprotective effects of estrogens"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   778   C0815279:Neuroprotective Effects [Functional Concept]
   774   C0877035:effects estrogens [Finding]
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: ":"

Phrase: "potential mechanisms of action."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   898   C0031327:mechanism of action [Physiologic Function]
   898   C1524059:mechanism of action [Functional Concept]
   770   C0441712:Mechanisms [Functional Concept]
   737 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.92: Int J Dev Neurosci 18:347358[CrossRef][Medline] Jaffe AB, Toran-Allerand CD, Greengard P, Gandy SE 1994 Estrogen regulates metabolism of Alzheimer amyloid  precursor protein. 

Phrase: "Int J Dev Neurosci 18"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0063789:INT [Organic Chemical]
   804   C3272375:INT [Intellectual Product]

Phrase: ":"

Phrase: "347358"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jaffe AB,"

Phrase: "Toran-Allerand CD,"

Phrase: "Greengard P,"

Phrase: "Gandy SE 1994 Estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "regulates"

Phrase: "metabolism of Alzheimer amyloid  precursor protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   864   C1327340:amyloid precursor protein metabolism [Molecular Function]
   783   C0597299:Protein Metabolism [Molecular Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.93: J Biol Chem 269:1306513068[Abstract/Free FullText] Luine VN 1985 Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1306513068"

Phrase: "[Abstract/Free FullText"

Phrase: "] Luine VN 1985 Estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   756 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   756 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "choline acetyltransferase activity in specific basal forebrain nuclei"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C1151953:choline acetyltransferase activity [Molecular Function]
   770   C1151922:acetyltransferase activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "projection areas of female rats."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0205146:areas [Spatial Concept]
   726 E C0017446:Area [Geographic Area]
Processing 00000000.tx.94: Exp Neurol 89:484490[Medline] Leranth C, Roth RH, Elsworth JD, Naftolin F, Horvath TL, Redmond Jr DE 2000 Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinsons disease and memory. 

Phrase: "Exp Neurol 89"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "484490"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Leranth C,"

Phrase: "Roth RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Elsworth JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Naftolin F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Horvath TL,"

Phrase: "Redmond Jr DE 2000 Estrogen"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   853   C0764313:DE estrogen [Pharmacologic Substance,Steroid]
   804   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   804   C2936882:Estrogen [Pharmacologic Substance]
   733 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "essential for maintaining nigrostriatal dopamine neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205224:Essential [Qualitative Concept]

Phrase: "in primates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033147:Primates [Mammal]

Phrase: ":"

Phrase: "implications for Parkinsons disease"

Phrase: "and"

Phrase: "memory."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]
Processing 00000000.tx.95: J Neurosci 20:86048609[Abstract/Free FullText] Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN 3rd, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J; 

Phrase: "J Neurosci 20"

Phrase: ":"

Phrase: "86048609"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shumaker SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Legault C,"

Phrase: "Rapp SR,"

Phrase: "Thal L,"

Phrase: "Wallace RB,"

Phrase: "Ockene JK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420098:JK [Gene or Genome]

Phrase: "Hendrix SL,"

Phrase: "Jones BN 3rd,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205437:3rd [Quantitative Concept]
   827   C0443013:Jones [Intellectual Product]

Phrase: "Assaf AR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986463:AR+ [Finding]

Phrase: "Jackson RD,"

Phrase: "Kotchen JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Wassertheil-Smoller S,"

Phrase: "Wactawski-Wende J"

Phrase: ";"
Processing 00000000.tx.96: WHIMS Investigators 2003 Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Womens Health Initiative Memory Study: a randomized controlled trial. 

Phrase: "WHIMS Investigators 2003 Estrogen plus progestin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0033306:Progestin [Hormone,Pharmacologic Substance,Steroid]
   799   C3536710:Progestin [Pharmacologic Substance]

Phrase: "and"

Phrase: "the incidence of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021149:Incidence [Quantitative Concept]
   770   C0220856:incidence [Functional Concept]

Phrase: "and"

Phrase: "mild cognitive impairment in postmenopausal women"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1270972:Mild Cognitive Impairment [Mental or Behavioral Dysfunction]
   790   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   753   C0684336:Impairment [Pathologic Function]

Phrase: ":"

Phrase: "the Womens Health Initiative Memory Study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0557651:Study [Manufactured Object]
   804   C2603343:Study [Research Activity]

Phrase: ":"

Phrase: "a randomized controlled trial."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0282440:randomized controlled trial [Intellectual Product,Research Activity]
  1000   C1096777:Randomized Controlled Trial [Intellectual Product,Research Activity]
   827   C0008976:Trial [Research Activity]
   827   C0034656:randomized [Research Activity]
   827   C2587213:Controlled [Functional Concept]
   793 E C0243148:control [Qualitative Concept]
   793 E C1550141:Control [Substance]
   793 E C1882979:Control [Conceptual Entity]
   793 E C3274648:Control [Qualitative Concept]
Processing 00000000.tx.97: JAMA 289:26512662[Abstract/Free FullText] Beral V 2003 Breast cancer and hormone-replacement therapy in the Million Women Study. 

Phrase: "JAMA 289"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422839:JAMA [Gene or Genome]

Phrase: ":"

Phrase: "26512662"

Phrase: "[Abstract/Free FullText"

Phrase: "] Beral V 2003 Breast cancer"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   840   C0006142:Breast Cancer [Neoplastic Process]
   840   C0678222:Breast Cancer [Neoplastic Process]
   804   C0006141:Breast [Body Part, Organ, or Organ Component]
   804   C0006826:Cancer [Neoplastic Process]
   804   C0998265:Cancer [Eukaryote]
   804   C1268990:Breast [Body Part, Organ, or Organ Component]
   804   C1306459:Cancer [Finding]
   790 E C0153661:thoracic cancer [Neoplastic Process]
   748 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   748 E C1521735:Pectoral [Qualitative Concept]
   721 E C0817096:Chest [Body Location or Region]
   721 E C1527391:Chest [Body Location or Region]

Phrase: "and"

Phrase: "hormone-replacement therapy in the Million Women"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   814   C0282402:Hormone replacement therapy [Therapeutic or Preventive Procedure]
           hormone replacement
   778   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   774   C0279025:Hormone Therapy [Therapeutic or Preventive Procedure]
   748   C0019932:Hormone [Hormone]
   748   C0035139:Replacement [Therapeutic or Preventive Procedure]
   748   C0039798:therapy [Functional Concept]
   748   C0087111:Therapy [Therapeutic or Preventive Procedure]
   748   C0559956:Replacement [Functional Concept]
   748   C1363945:Therapy [Finding]
   748   C1555302:Replacement [Idea or Concept]

Phrase: "Study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.98: Lancet 362:419427[CrossRef][Medline] Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD 2002 Postmenopausal hormone replacement therapy: scientific review. 

Phrase: "Lancet 362"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ":"

Phrase: "419427"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nelson HD,"

Phrase: "Humphrey LL,"

Phrase: "Nygren P,"

Phrase: "Teutsch SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Allan JD 2002 Postmenopausal hormone replacement therapy"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   877   C0019930:Hormone Replacement Therapy, Post-Menopausal [Therapeutic or Preventive Procedure]
   845   C0282402:Hormone replacement therapy [Therapeutic or Preventive Procedure]
           hormone replacement
   829   C0279025:Hormone Therapy [Therapeutic or Preventive Procedure]
   818   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   795   C0035139:Replacement [Therapeutic or Preventive Procedure]
   795   C0039798:therapy [Functional Concept]
   795   C0087111:Therapy [Therapeutic or Preventive Procedure]
   795   C0559956:Replacement [Functional Concept]
   795   C1363945:Therapy [Finding]
   795   C1555302:Replacement [Idea or Concept]

Phrase: ":"

Phrase: "scientific review."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282443:Review [Intellectual Product]
   861   C1552617:Review [Idea or Concept]
Processing 00000000.tx.99: JAMA 288:872881[Abstract/Free FullText] Lehtimaki T, Dastidar P, Jokela H, Koivula T, Lehtinen S, Ehnholm C, Punnonen R 2002 Effect of long-term hormone replacement therapy on atherosclerosis progression in postmenopausal women relates to functional apolipoprotein E genotype. 

Phrase: "JAMA 288"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422839:JAMA [Gene or Genome]

Phrase: ":"

Phrase: "872881"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lehtimaki T,"

Phrase: "Dastidar P,"

Phrase: "Jokela H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Koivula T,"

Phrase: "Lehtinen S,"

Phrase: "Ehnholm C,"

Phrase: "Punnonen R 2002 Effect of long-term hormone replacement therapy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   777   C0023983:Long-Term Effect [Phenomenon or Process]
   757   C1518681:Therapy Effect [Finding]
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "on atherosclerosis progression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0242656:progression [Pathologic Function]
   861   C0449258:Progression [Functional Concept]

Phrase: "in postmenopausal women"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0043210:Women [Population Group]
   861   C0232970:postmenopausal [Temporal Concept]

Phrase: "relates to functional apolipoprotein E genotype."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0017431:Genotype [Organism Attribute]
   753   C0163712:Relate [Organic Chemical]
   753   C0205245:Functional [Functional Concept]
   753   C0542341:Functional [Functional Concept]
   753   C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.100: J Clin Endocrinol Metab 87:41474153[Abstract/Free FullText] Fazekas F, Strasser-Fuchs S, Kollegger H,Berger T, Kristoferitsch W, Schmidt H, Enzinger C, Schiefermeier M, Schwarz C, Kornek B, Reindl M, Huber K, Grass R, Wimmer G, Vass K, Pfeiffer KH, Hartung HP, Schmidt R 2001 Apolipoprotein E 4 is associated with rapid progression of multiple sclerosis. 

Phrase: "J Clin Endocrinol Metab 87"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "41474153"

Phrase: "[Abstract/Free FullText"

Phrase: "] Fazekas F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Strasser-Fuchs S,"

Phrase: "Kollegger H,Berger T,"

Phrase: "Kristoferitsch W,"

Phrase: "Schmidt H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Enzinger C,"

Phrase: "Schiefermeier M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Schwarz C,"

Phrase: "Kornek B,"

Phrase: "Reindl M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Huber K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Grass R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Wimmer G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Vass K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Pfeiffer KH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006797:KH [Geographic Area]

Phrase: "Hartung HP,"

Phrase: "Schmidt R 2001 Apolipoprotein E 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   827   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "associated with rapid progression of multiple sclerosis."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   778   C0026769:Multiple Sclerosis [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1417325:multiple sclerosis [Gene or Genome]
   778   C1838681:Rapid progression [Finding]
   748   C0036429:Sclerosis [Pathologic Function]
   748   C0242656:progression [Pathologic Function]
   748   C0439064:Multiple [Quantitative Concept]
   748   C0439831:Rapid [Qualitative Concept]
   748   C0449258:Progression [Functional Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.101: Neurology 57:853857[Abstract/Free FullText] Tang G, Xie H, Xu L, Hao Y, Lin D, Ren D 2002 Genetic study of apolipoprotein E gene, -1 antichymotrypsin gene in sporadic Parkinson disease. 

Phrase: "Neurology 57"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ":"

Phrase: "853857"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tang G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Xie H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Xu L,"

Phrase: "Hao Y,"

Phrase: "Lin D,"

Phrase: "Ren D 2002 Genetic study of apolipoprotein E gene, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C2827447:Genetic Study [Research Activity]
   742   C0557651:Study [Manufactured Object]
   742   C2603343:Study [Research Activity]

Phrase: "1 antichymotrypsin gene in sporadic Parkinson disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0017337:Gene [Gene or Genome]
   746   C1416989:MAL gene [Gene or Genome]
Processing 00000000.tx.102: Am J Med Genet 114:446449[CrossRef][Medline] Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA 1993 Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimers disease in late onset families. 

Phrase: "Am"

Phrase: "J Med Genet 114"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "446449"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Corder EH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520135:EH [Geographic Area]

Phrase: "Saunders"

Phrase: "AM"

Phrase: ","

Phrase: "Strittmatter WJ,"

Phrase: "Schmechel DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Gaskell PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: "Small GW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018387:GW [Geographic Area]

Phrase: "Roses AD,"

Phrase: "Haines JL,"

Phrase: "Pericak-Vance MA 1993 Gene dose of apolipoprotein E type 4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0178602:Dose [Quantitative Concept]
   736   C0869039:Dose [Quantitative Concept]
   736   C1114758:Dose # [Clinical Attribute]

Phrase: "and"

Phrase: "the risk of Alzheimers disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "in late onset families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.103: Science 261:921923[Medline] Yaffe K, Haan M, Byers A, Tangen C, Kuller L 2000 Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction. 

Phrase: "Science 261"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "921923"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yaffe K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Haan M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Byers A,"

Phrase: "Tangen C,"

Phrase: "Kuller L 2000 Estrogen use,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0239301:ESTROGEN USE [Finding]
   804   C0042153:use [Functional Concept]
   804   C0457083:Use [Functional Concept]
   804   C1947944:Use [Intellectual Product]

Phrase: "APOE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "and"

Phrase: "cognitive decline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]

Phrase: ":"

Phrase: "evidence of gene-environment interaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332120:Evidence of [Functional Concept]
           Evidence
Processing 00000000.tx.104: Neurology 54:19491954[Abstract/Free FullText] Struble RG, Rosario ER, Kircher ML,Ludwig SM, McAdamis PJ, Watabe K, McAsey ME, Cady C, Nathan BP 2003 Regionally specific modulation of brain apolipoprotein E in the mouse during the estrous cycle and by exogenous 17 estradiol. 

Phrase: "Neurology 54"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ":"

Phrase: "19491954"

Phrase: "[Abstract/Free FullText"

Phrase: "] Struble RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Rosario ER,"

Phrase: "Kircher ML,Ludwig SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0036154:SM [Geographic Area]

Phrase: "McAdamis PJ,"

Phrase: "Watabe K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "McAsey"

Phrase: "ME,"

Phrase: "Cady C,"

Phrase: "Nathan BP 2003 Regionally specific modulation of brain apolipoprotein E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0443264:Modulation [Spatial Concept]

Phrase: "in the mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "during the estrous cycle"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0025329:estrous cycle [Organism Function]
  1000   C0950151:Estrous Cycle [Organism Function]
   861   C0014948:estrous [Organism Function]
   861   C1511572:Cycle [Temporal Concept]

Phrase: "and by exogenous 17 estradiol."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   760   C0205101:Exogenous [Spatial Concept]
   760   C0205228:Exogenous [Functional Concept]
   760   C1515981:And [Idea or Concept]
   704 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   704 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]
Processing 00000000.tx.105: Exp Neurol 183:638644[CrossRef][Medline] Srivastava RA, Krul ES, Lin RC, Schonfeld G 1997 Regulation of lipoprotein metabolism by estrogen in inbred strains of mice occurs primarily by posttranscriptional mechanisms. 

Phrase: "Exp Neurol 183"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "638644"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Srivastava RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Krul ES,"

Phrase: "Lin RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Schonfeld G 1997 Regulation of lipoprotein metabolism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1327341:regulation of lipoprotein metabolism [Molecular Function]
   804   C1159402:regulation of metabolism [Organism Function]
           metabolism regulation
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "by estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "in inbred strains"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C1512692:Inbred Strain [Organism]
   861   C0080194:Strains [Injury or Poisoning]
   861   C0456178:strains [Intellectual Product]
   827 E C1518614:Strain [Organism]
   827 E C2987481:Strain [Mental Process]

Phrase: "of mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "primarily by posttranscriptional mechanisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441712:Mechanisms [Functional Concept]
   737 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.106: Mol Cell Biochem 173:161168[CrossRef][Medline] Nathan BP, Jiang Y, Wong GK, Shen F, Brewer GJ, Struble RG 2002 Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein. 

Phrase: "Mol Cell Biochem 173"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "161168"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nathan BP,"

Phrase: "Jiang Y,"

Phrase: "Wong GK,"

Phrase: "Shen F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Brewer GJ,"

Phrase: "Struble RG 2002 Apolipoprotein E4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   804   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: ","

Phrase: "and"

Phrase: "apolipoprotein E3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0052199:Apolipoprotein E-3 [Amino Acid, Peptide, or Protein]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1537525:E3 [Gene or Genome]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "neurite outgrowth in cultured adult mouse cortical neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C3158384:neurite outgrowth [Cell Function]
   744   C0085103:Neurite [Cell Component]

Phrase: "through the low-density lipoprotein receptor-related protein."
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   901   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   901   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   895   C0242972:low protein [Therapeutic or Preventive Procedure]
   895   C0748025:low protein [Finding]
   861   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   839   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   827   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0178587:density [Quantitative Concept]
   799   C0205251:low [Qualitative Concept]
   799   C0439849:Related [Qualitative Concept]
   799   C0445223:Related [Finding]
   799   C1299352:Low [Qualitative Concept]
   799   C1550472:low [Idea or Concept]
   766 E C0163712:Relate [Organic Chemical]
   727 E C0080103:Relation [Family Group]
   727 E C0439794:Dense [Qualitative Concept]
   727 E C0869014:Relations [Social Behavior]
Processing 00000000.tx.107: Brain Res 928:96105[CrossRef][Medline] Horsburgh K, Macrae IM, Carswell H 2002 Estrogen is neuroprotective via an apolipoprotein E-dependent mechanism in a mouse model of global ischemia. 

Phrase: "Brain Res 928"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "96105"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Horsburgh K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Macrae IM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539078:IM [Idea or Concept]

Phrase: "Carswell H 2002 Estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "neuroprotective via an apolipoprotein E-dependent mechanism"

Phrase: "in a mouse model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2986594:Mouse Model [Experimental Model of Disease]
   861   C3161035:Model [Intellectual Product]

Phrase: "of global ischemia."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0022116:Ischaemia [Disease or Syndrome]
   861   C0205246:Global [Spatial Concept]
   861   C2348867:Global [Qualitative Concept]
   789 E C0015392:globe [Body Part, Organ, or Organ Component]
   789 E C0475224:Ischaemic [Functional Concept]
   789 E C1280202:Globe [Body Part, Organ, or Organ Component]
Processing 00000000.tx.108: J Cereb Blood Flow Metab 22:11891195[CrossRef][Medline] Stone DJ, Rozovsky I, Morgan TE, Anderson CP, Finch CE 1998 Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimers disease. 

Phrase: "J Cereb Blood Flow Metab 22"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   827   C0232338:Blood flow [Organism Function]
   799   C0005767:Blood [Tissue]
   799   C0005768:blood [Body Substance]
   799   C0229664:Blood [Body Substance]
   799   C0806140:Flow [Natural Phenomenon or Process]
   727 E C0333275:Bloody [Qualitative Concept]
   716 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   716 E C0392895:Bloods [Population Group]
   716 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   716 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: ":"

Phrase: "11891195"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stone DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Rozovsky I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Morgan TE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039462:Te [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   861   C1705540:TE [Conceptual Entity]

Phrase: "Anderson CP,"

Phrase: "Finch CE 1998 Increased synaptic sprouting in response"

Phrase: "to estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "via an apolipoprotein E-dependent mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0441712:Mechanism [Functional Concept]
   812   C1706376:Mechanism [Manufactured Object]

Phrase: ":"

Phrase: "implications for Alzheimers disease."
Processing 00000000.tx.109: J Neurosci 18:31803185[Abstract/Free FullText] Toran-Allerand CD, Guan X, MacLusky NJ, Horvath TL, Diano S, Singh M, Connolly Jr ES, Nethrapalli IS, Tinnikov AA 2002 ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. 

Phrase: "J Neurosci 18"

Phrase: ":"

Phrase: "31803185"

Phrase: "[Abstract/Free FullText"

Phrase: "] Toran-Allerand CD,"

Phrase: "Guan X,"

Phrase: "MacLusky NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Horvath TL,"

Phrase: "Diano S,"

Phrase: "Singh M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Connolly Jr ES,"

Phrase: "Nethrapalli"

Phrase: "IS"

Phrase: ","

Phrase: "Tinnikov AA 2002 ER-X"

Phrase: ":"

Phrase: "a novel, plasma membrane-associated, putative estrogen receptor"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0230664:Membrane receptor [Receptor]
   818   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   818   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   818   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C2936882:Estrogen [Pharmacologic Substance]
   724 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "that"

Phrase: "is"

Phrase: "regulated during development"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0243107:development [Physiologic Function]
   790   C0678723:Development [Organism Function]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   790   C1527148:Development [Functional Concept]
   718 E C0458003:Developmental [Qualitative Concept]

Phrase: "and after ischemic brain injury."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C2945681:ischemic brain injury [Injury or Poisoning]
   806   C0270611:Brain Injury [Injury or Poisoning]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0475224:Ischaemic [Functional Concept]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1515981:And [Idea or Concept]
   760   C3263722:Injury [Injury or Poisoning]
   760   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.110: J Neurosci 22:83918401[Abstract/Free FullText] Sandstrom NJ, Williams CL 2004 Spatial memory retention is enhanced by acute and continuous estradiol replacement. 

Phrase: "J Neurosci 22"

Phrase: ":"

Phrase: "83918401"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sandstrom NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Williams CL 2004 Spatial memory retention"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0598851:memory retention [Mental Process]
   799   C0035280:Retention [Mental Process]
   799   C0333117:Retention [Functional Concept]
   799   C1753315:retention [Cell Function]

Phrase: "is"

Phrase: "enhanced by acute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205178:acute [Temporal Concept]
   790   C2349975:Enhanced [Activity]

Phrase: "and"

Phrase: "continuous estradiol replacement."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1555302:Replacement [Idea or Concept]
Processing 00000000.tx.111: Horm Behav 45:128135[CrossRef][Medline] Nilsen J, Brinton RD 2002 Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. 

Phrase: "Horm Behav 45"

Phrase: ":"

Phrase: "128135"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nilsen J,"

Phrase: "Brinton RD 2002 Impact of progestins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1825598:IMPACT [Gene or Genome]

Phrase: "on estrogen-induced neuroprotection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0598958:Neuroprotection [Cell Function]

Phrase: ":"

Phrase: "synergy by progesterone"

Phrase: "and"

Phrase: "19-norprogesterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045076:19-norprogesterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "antagonism by medroxyprogesterone acetate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680242:antagonism [Social Behavior]
Processing 00000000.tx.112: Endocrinology 143:205212[Abstract/Free FullText] Moffat SD, Zonderman AB, Metter EJ, Kawas C, Blackman MR, Harman SM, Resnick SM 2004 Free testosterone and risk for Alzheimer disease in older men. 

Phrase: "Endocrinology 143"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "205212"

Phrase: "[Abstract/Free FullText"

Phrase: "] Moffat SD,"

Phrase: "Zonderman AB,"

Phrase: "Metter EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "Kawas C,"

Phrase: "Blackman MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Harman SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Resnick SM 2004 Free testosterone"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   840   C0202228:Testosterone, Free [Laboratory Procedure]
   840   C0443483:Free testosterone [Hormone,Steroid]
   804   C0039601:Testosterone [Hormone,Pharmacologic Substance,Steroid]
   804   C0332296:free [Functional Concept]
   804   C1880497:Free [Qualitative Concept]
   804   C1996904:Free [Qualitative Concept]
   748 E C0113075:Depo-testosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "risk for Alzheimer disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1281905:disease risk [Finding]
   770   C0035647:Risk [Qualitative Concept]

Phrase: "in older men."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0025266:Men [Population Group]
   827 E C0024554:MAN [Finding]
   827 E C0086418:Man [Human]
Processing 00000000.tx.113: Neurology 62:188193[Abstract/Free FullText] Sunderland T, Merril CR, Harrington MG, Lawlor BA, Molchan SE, Martinez R, Murphy DL 1989 Reduced plasma dehydroepiandrosterone concentrations in Alzheimers disease. 

Phrase: "Neurology 62"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ":"

Phrase: "188193"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sunderland T,"

Phrase: "Merril CR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: "Harrington MG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "Lawlor BA,"

Phrase: "Molchan SE,"

Phrase: "Martinez R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Murphy DL 1989 Reduced plasma dehydroepiandrosterone concentrations in Alzheimers disease."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   757   C0683150:concentrations plasma [Quantitative Concept]
   741   C0424099:Reduced concentration [Finding]
   739   C0086045:Concentrations [Mental Process]
   706 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.114: Lancet 2:570[Medline] Leranth C, Hajszan T, MacLusky NJ 2004 Androgens increase spine synapse density in the CA1 hippocampal subfield of ovariectomized female rats. 

Phrase: "Lancet 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ":"

Phrase: "570"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Leranth C,"

Phrase: "Hajszan T,"

Phrase: "MacLusky NJ 2004 Androgens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0002844:Androgens [Hormone,Pharmacologic Substance]
   779 E C3536949:Androgen [Pharmacologic Substance]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "spine synapse density in the CA1 hippocampal subfield of ovariectomized female rats."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0178587:density [Quantitative Concept]
Processing 00000000.tx.115: J Neurosci 24:495499[Abstract/Free FullText] Bastianetto S, Ramassamy C, Poirier J, Quirion R 1999 Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. 

Phrase: "J Neurosci 24"

Phrase: ":"

Phrase: "495499"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bastianetto S,"

Phrase: "Ramassamy C,"

Phrase: "Poirier J,"

Phrase: "Quirion R 1999 Dehydroepiandrosterone (DHEA)"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0011185:dehydroepiandrosterone [Hormone,Pharmacologic Substance,Steroid]
   756 E C0373598:Dehydroisoandrosterone [Laboratory Procedure]

Phrase: "protects"

Phrase: "hippocampal cells from oxidative stress-induced damage."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   774   C0599732:cells damage [Cell or Molecular Dysfunction]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.116: Brain Res Mol Brain Res 66:3541[Medline] Hogervorst E, Lehmann DJ, Warden DR, McBroom J, Smith AD 2002 Apolipoprotein E 4 and testosterone interact in the risk of Alzheimers disease in men. 

Phrase: "Brain Res Mol Brain Res 66"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   799   C0006104:Brain [Body Part, Organ, or Organ Component]
   799   C0027960:Mole [Neoplastic Process]
   799   C0324740:Mole [Mammal]
   799   C0439189:Mole [Quantitative Concept]
   799   C1269537:Brain [Body Part, Organ, or Organ Component]
   799   C1456781:mole [Neoplastic Process]
   799   C1824986:mol [Gene or Genome]
   799   C2347379:RES [Finding]
   716 E C0026367:Molar [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "3541"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hogervorst E,"

Phrase: "Lehmann DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Warden DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "McBroom J,"

Phrase: "Smith AD 2002 Apolipoprotein E 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   827   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "testosterone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0039601:Testosterone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0113075:Depo-testosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "interact in the risk of Alzheimers disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0002395:Alzheimers disease [Disease or Syndrome]
   774   C1281905:disease risk [Finding]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0035647:Risk [Qualitative Concept]

Phrase: "in men."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]
Processing 00000000.tx.117: Int J Geriatr Psychiatry 17:938940[CrossRef][Medline] Levin-Allerhand J, McEwen BS, Lominska CE, Lubahn DB, Korach KS, Smith JD 2001 Brain region-specific up-regulation of mouse apolipoprotein E by pharmacological estrogen treatments. 

Phrase: "Int J Geriatr Psychiatry 17"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0033872:Psychiatry [Professional or Occupational Group]
   804   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   804   C0063789:INT [Organic Chemical]
   804   C3272375:INT [Intellectual Product]
   733 E C0205487:Psychiatric [Functional Concept]

Phrase: ":"

Phrase: "938940"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Levin-Allerhand J,"

Phrase: "McEwen BS,"

Phrase: "Lominska CE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827664:CE [Idea or Concept]

Phrase: "Lubahn DB,"

Phrase: "Korach KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Smith JD 2001 Brain region-specific up-regulation of mouse apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0851285:Regulation [Governmental or Regulatory Activity]
   736   C1327622:Regulation [Biologic Function]

Phrase: "by pharmacological estrogen treatments."
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   913   C0013216:Pharmacological Treatments [Therapeutic or Preventive Procedure]
   827   C0087111:Treatments [Therapeutic or Preventive Procedure]
   793 E C0039798:treatment [Functional Concept]
   793 E C1522326:Treatment [Functional Concept]
   793 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   793 E C1705169:Treatment [Conceptual Entity]
   793 E C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.118: J Neurochem 79:796803[CrossRef][Medline] Rozovsky I, Hoving S, Anderson CP, OCallaghan J, Finch CE 2002 Equine estrogens induce apolipoprotein E and glial fibrillary acidic protein in mixed glial cultures. 

Phrase: "J Neurochem 79"

Phrase: ":"

Phrase: "796803"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rozovsky I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Hoving S,"

Phrase: "Anderson CP,"

Phrase: "OCallaghan J,"

Phrase: "Finch CE 2002 Equine estrogens"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   771 E C2936882:Estrogen [Pharmacologic Substance]
   721 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "glial fibrillary acidic protein in mixed glial cultures."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0017626:Glial Fibrillary Acidic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1325793:glial fibrillary acidic protein [Cell Component]
   833   C1415042:GLIAL FIBRILLARY ACIDIC PROTEIN [Gene or Genome]
   744   C0001128:Acidic [Chemical]
   744   C0027836:Glial [Cell]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.119: Neurosci Lett 323:191194[CrossRef][Medline]

Phrase: "Neurosci Lett 323"

Phrase: ":"

Phrase: "191194"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

